Commonly used anti-rejection drug could be repurposed to treat some liver cancers: Serendipitous observation opens the door for a precision medicine treatment

Commonly used anti-rejection drug could be repurposed to treat some liver cancers: Serendipitous observation opens the door for a precision medicine treatment

Research in animal models and patient tissues has identified a new molecular pathway in the liver that suggests a commonly used anti-rejection medication could be repurposed to treat certain liver cancers.

  • 0 Likes

  • 0 Comments

See posts by others with similar interest